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The mammalian lung forms its elaborate tree-like
structure following a largely stereotypical branching
sequence. While a number of genes have been iden-
tified to play essential roles in lung branching, what
coordinates the choice between branch growth and
new branch formation has not been elucidated.
Here we show that loss of FGF-activated transcrip-
tion factor genes, Etv4 and Etv5 (collectively Etv),
led to prolonged branch tip growth and delayed
new branch formation. Unexpectedly, this pheno-
type is more similar to mutants with increased rather
than decreased FGF activity. Indeed, an increased
Fgf10 expression is observed, and reducing Fgf10
dosage can attenuate the Etv mutant phenotype.
Further evidence indicates that ETV inhibits Fgf10
via directly promoting Shh expression. SHH in turn
inhibits local Fgf10 expression and redirects growth,
thereby initiating new branches. Together, our find-
ings establish ETV as a key node in the FGF-ETV-
SHH inhibitory feedback loop that dictates branching
periodicity.
INTRODUCTION
In the mammalian lung, multiple rounds of branching morpho-
genesis are essential for generating the surface area required
for efficient gas exchange. In mice, lung development initiates
at embryonic day (E) 9.5, with the outgrowth of a pair of epithelial
buds from the embryonic foregut (Cardoso and Lu¨, 2006; Morri-
sey and Hogan, 2010). Subsequently, these buds elongate and
begin the process of branching morphogenesis. During this pro-
cess, new tips emerge through one of three defined modes of
epithelial branching (Metzger et al., 2008; Short et al., 2013).
The largely stereotypical nature of the branching sequence sug-
gests strict genetic control of this process.
Many signaling pathways play critical roles in lung develop-
ment (Warburton et al., 2005; Cardoso and Lu¨, 2006; Morrisey
and Hogan, 2010). At the center of these is the fibroblast growth
factor (hereafter FGF) signaling pathway. Multiple FGF ligands322 Developmental Cell 35, 322–332, November 9, 2015 ª2015 Elsevand all four FGF receptors are expressed in the lung at varying
stages of development (Warburton et al., 2005; Cardoso and
Lu¨, 2006;Morrisey andHogan, 2010; Yu et al., 2010). The earliest
requirement of FGF signaling is for FGF10 expressed in the
mesoderm, which signals through the FGFR2IIIb isoform in the
epithelium and is essential for the formation of the initial lung
buds (Min et al., 1998; Sekine et al., 1999; De Moerlooze et al.,
2000). During branching morphogenesis, FGF10 acts as a che-
moattractant for the distal epithelium (Bellusci et al., 1997b;
Weaver et al., 2000), although whether localized Fgf10 expres-
sion is essential for branch formation is debated (Volckaert
et al., 2013). This requirement for FGF10 in epithelial branch
outgrowth is illustrated by Fgf10 hypomorphs and Fgf10 condi-
tional knockout mice, which develop reduced lung epithelial
branch number (Mailleux et al., 2005; Abler et al., 2009).
FGF has been shown to regulate the expression of multiple
signaling pathway genes, the most prominent of which is sonic
hedgehog (hereafter Shh) (Bellusci et al., 1997b; Pepicelli et al.,
1998; Abler et al., 2009). In the lung, FGF10 and SHH form a
feedback loop where FGF10 produced in the mesenchyme sig-
nals to the distal epithelium to upregulate Shh expression. SHH
then feeds back to inhibit Fgf10 expression in the adjacent
mesenchyme, which in effect splits the Fgf10 expression
domain in two. It is postulated that the new FGF10 signaling do-
mains serve as two chemoattractant sources, which direct the
bifurcation of the epithelial tip. This hypothesis is supported
by mathematical modeling studies suggesting that the FGF10-
SHH feedback loop is a central driver of the branching program
(Hirashima et al., 2009; Menshykau et al., 2012; Iber and Men-
shykau, 2013). While each of the signaling components of
the feedback loop has been shown to be essential for branch-
ing, how the balanced coordination of this feedback loop im-
pacts branch growth and new branch formation has not been
demonstrated.
In the FGF10-SHH feedback loop, FGF10 and SHH regulate
each other’s expression on the transcript level. Interestingly,
while many studies have been devoted to examining the function
of signaling pathway ligands and receptors during lung develop-
ment, relatively few studies have examined how the downstream
components, e.g., transcription factors, mediate this process.
Consequently, the transcription factors involved in the FGF10-
SHH feedback loop remain unknown. We have previously per-
formed a genome-scale transcription factor in situ hybridization
screen to identify genes expressed in the branching lungier Inc.
Figure 1. Inactivation of Etv in the Lung
Epithelium Led to Epithelial Branching
Defects
(A) Etv5 inactivation was efficient as evidenced by
the clear reduction of full-length transcripts in the
Etvmutant lung (E11.5: 1.0 for controls, 0.14 for Etv
mutants, p = 0.005; E12.5: 1.0 for controls, 0.15 for
Etvmutants, p = 0.02, and n = 3 each group).
(B–I) Representative control (B, D, F, and H) and
Etv mutant (C, E, G, and I) whole lungs with
epithelium outlined by anti-E-cadherin immuno-
histochemical staining. In the mutant, the tip
dilation phenotype was already apparent at E10.5
(arrowhead in C). The reduced tip number
phenotype was apparent shortly after the initiation
of secondary branching at E11.5; the position of
the bud for the future accessory lobe was shifted
more posteriorly compared to control (arrow-
heads in D and E).
(J) Tip area is increased in the left lung at the
indicated stages (E12.5: 1.0 for controls and 3.08
for Etv mutants, p = 0.001; E13.5: 1.0 for controls
and 2.05 for Etv mutants, p = 0.018).
(K) Tip number is decreased in the Etvmutant Left
lung at the indicated stages (E11.5: 1.0 for con-
trols, 0.5 for Etv mutants, p = 0.004; E12.5: 1.0 for
controls, 0.55 for Etv mutants, p = 0.011; E13.5:
1.0 for controls, 0.67 for Etv mutants, p = 0.024.
Actual tip numbers at the three stages shown are
E11.5: control 3.50 ± 0.57 versus mutant 1.75 ±
0.50; E12.5: control 9.67 ± 1.15 versus mutant
5.33 ± 0.58; and E13.5: control 16.00 ± 2.00
versus mutant 10.67 ± 1.53).
Examples of how the tip areas were defined were indicated by arrowheads and outlined in the insets in (F) and (G). Quantification was carried out in n R 4
samples for each genotype and stage. Data are presented as SEM, as in graphs in all figures. See also Figure S1.(Herriges et al., 2012). From this screen, we identified the PEA3
group ETS domain transcription factor Etv5 as a gene expressed
in the distal epithelium. Etv5 is one of three PEA3 group tran-
scription factor genes, all of which are expressed in the devel-
oping lung. However, only Etv4 and Etv5 (hereafter collectively
Etv) are strongly expressed in the lung epithelium (Chotteau-Le-
lie`vre et al., 1997; Liu et al., 2003; Herriges et al., 2012). Previous
studies have shown that exogenous FGF can induce Etv expres-
sion in the lung, making them attractive candidates for mediating
FGF function during lung development (Liu et al., 2003; Lin et al.,
2006). In addition, overexpression of a dominant-negative ETV5-
Engrailed repressor fusion protein has suggested that ETV tran-
scription factors are necessary for proper epithelial patterning
and cell differentiation (Liu et al., 2003). However, the potential
role of ETV factors in mediating FGF function during branching
morphogenesis remains unclear.
In this study we conditionally inactivated Etv genes in the lung
epithelium and demonstrated that this leads to dilation of
branch tips and reduced branch number. The epithelial Etv
mutant lungs exhibit increased Fgf10 expression and decreased
Shh expression. Our data suggest that ETV factors act as inter-
mediates in the FGF-SHH negative feedback loop, by acting
downstream of FGF signaling and promoting the activity of a
long-range Shh enhancer. Loss of Etv thereby tipped the bal-
ance of the FGF-SHH feedback loop, leading to an altered
branching periodicity, resulting in increased tip size and
decreased tip number.DevelopmRESULTS
Inactivation of Etv4 and Etv5 Led to Dilated Branch Tips
and Reduced Branch Number
To investigate the requirement for Etv during development, we
inactivated both Etv4 and Etv5 (hereafter collectively Etv) in the
embryonic lung epithelium, a cell layer where they are co-ex-
pressed (Figures S1A–S1D). This was achieved by combining
an epithelial-specific Shhcre allele with a conditional Etv5fl allele
and a null Etv4 allele, which generated Shhcre/+;Etv4/;Etv5fl/fl
(hereafter Etv mutant) embryos (Laing et al., 2000; Harfe et al.,
2004; Zhang et al., 2009). We used Shhcre/+;Etv4+/;Etv5fl/+ as
controls unless otherwise stated. In the mutant, there was an
85% reduction of the full-length Etv5 transcript by E11.5,
demonstrating efficient inactivation by CRE (Figure 1A). In
addition to the Etv mutant, both Shhcre/+;Etv4+/+;Etv5fl/fl and
Shhcre/+;Etv4+/;Etv5fl/fl embryos exhibited lung branching phe-
notypes similar to albeit not as severe as the Etv mutant, while
other genotypes were normal (data not shown). In addition,
further inactivating Etv1 in the Etv mutant background (gener-
ating Shhcre/+;Etv1fl/fl;Etv4/;Etv5fl/fl embryos) did not alter the
phenotypes, consistent with the observation that Etv1 is primar-
ily expressed in the lung mesenchyme (data not shown) (Chot-
teau-Lelie`vre et al., 1997). Henceforth, we focused our analysis
on the Etv mutant (Shhcre/+;Etv4/;Etv5fl/fl), as it exhibits the
most severe lung phenotypes among the genotypes listed
above.ental Cell 35, 322–332, November 9, 2015 ª2015 Elsevier Inc. 323
While Etvmutants did survive and appear to have a normal life-
span, they displayed smaller lungs at birth despite a normal
overall body size (Figures S1E and S1F). In tracing back the
lung hypoplasia phenotype, we found that Etv mutant lungs ex-
hibited morphological defects as early as E10.5, shortly after
lung bud initiation (Figures 1B and 1C). Anti-E-cadherin antibody
labeling of the epithelium revealed that the distal tips of nascent
buds, especially the larger right lung bud, were consistently
dilated in the mutant compared to control (Figure 1C, arrow-
head). This tip dilation phenotype remained apparent throughout
branching morphogenesis, and the increase in tip size was sta-
tistically significant at both E12.5 and E13.5, as quantified either
in two dimensions or in three dimensions (Figures 1D–1J and
S1G–S1I;Movies S1 and S2). Branch number was reduced start-
ing at E11.5 and persisted throughout the branching program
(Figures 1D–1I and 1K).
A significant contributor to reducedbranch number is a delay in
branch formation. For example, at E11.5 in the left lobe, while two
domain branches had formed in the control, none was observed
in the mutant (Figures 1D and 1E). However, by E12.5, it is
apparent that the initial domain branches had formed, but the to-
tal branch numberwas still fewer compared to control (Figures 1F
and 1G). All three branch subroutines (domain branching, planar
bifurcation, and orthogonal bifurcation) were observed in the
mutant, but all were reduced in number (Metzger et al., 2008;
Short et al., 2013). These reductions resulted in mutant lungs
that were roughly the same shape but reduced in size compared
to control (Figures S1E and S1F). No changes in cell proliferation
or cell death were observed in either the lung epithelium or
mesenchyme, suggesting that the morphological changes may
be a combined result of cumulating subtle reduction in cell prolif-
eration rate and altered cell morphogenesis (Figures S1J–S1M).
Taken together, these results indicate thatEtv genes are required
in the epithelium for proper branching morphogenesis.
Cell Differentiation Is Largely Unperturbed inEtvMutant
Lungs
To determine whether Etv genes play a role in lung patterning
and/or cell differentiation, we first analyzed the expression of
Sox2 and Sox9, markers for proximal versus distal epithelial
cells, respectively. At E12.5 by qRT-PCR analysis, there is no dif-
ference in Sox9 expression but a trending increase in Sox2
expression. However, by RNA whole-mount in situ hybridization,
both genes are expressed in largely expected domains in the
context of a dysmorphic lung, suggesting no overt patterning de-
fects (Figures S2A–S2E). We then analyzed the various cell types
in the airway or alveolar epithelium. All analyzed cell types,
including club cells, pulmonary neuroendocrine cells, ciliated
cells, basal cells, and type I and type II cells, appear present in
normal proportion (Figures 2A–2H and S2F–S2I). This result is
unexpected as it is distinct from the reported airway and alveolar
cell differentiation defects in transgenic lungs where an ETV5-
Engrailed transcriptional repressor domain fusion protein was
overexpressed in the lung epithelium (Liu et al., 2003). This differ-
ence raises the possibility that the phenotypes in the transgenic
line may be due to inhibitory effects of the ETV5-Engrailed fusion
proteins on factors other than ETV4 and ETV5.
While all epithelial cell types are present in normal proportion,
whole-mount staining of Scgb1a1, a club cell marker, outlines324 Developmental Cell 35, 322–332, November 9, 2015 ª2015 Elsevairways that are enlarged in diameter and reduced in number
(Figures 2I–2K). This pattern indicates that the earlier branching
defect has a profound impact on later airway organization.
We also analyzed the mesenchymal cell types in the Etv mu-
tants. We found that the smooth muscle cells and endothelial
cells are normal (Figures S2J–S2M). In contrast, there is a reduc-
tion and disorganization of cartilage cells (Figures S2N and S2O),
suggesting that there is a non-autonomous effect of loss of Etv in
the epithelium on cartilage differentiation in the mesenchyme.
FGFSignaling Is Increased Rather thanDecreased inEtv
Mutant Lungs
As FGF promotes Etv expression, we postulated that Etv may
serve as a positive mediator of FGF function. Surprisingly, the in-
crease in tip size observed in Etvmutant lungs was more similar
to mutants with increased, rather than decreased, FGF signaling
(Abler et al., 2009; Tang et al., 2011; Volckaert et al., 2013). To
determine whether and how FGF activity was altered in the
mutant, we examined the pattern of phosphorylated-ERK (here-
after pERK), a commonly assayed readout of FGF activity, using
immunofluorescent staining. The pERK signal was elevated in in-
tensity and expanded in domain in the mutant epithelium
compared to the control (Figures 3A–3F and S3A–S3F). Consis-
tent with the expansion of the pERK domain, there is an increase
in the expression of Spry2 and Bmp4, two genes known to be
promoted by FGF activity by both RNA in situ hybridization and
qRT-PCR (Figures S3G–S3K) (Abler et al., 2009).
To trace the cause of this increase in FGF activity, we exam-
ined the expression of upstream FGF pathway components. Us-
ing qRT-PCR, we found that the expression of Fgf10, a principal
FGF ligand that is critical for branching, was significantly
increased in the Etv mutant lung (Figure 3G). Consistent with
this Fgf10 increase, we found that there was an expansion of
the Fgf10 expression domains in the mutant lung (Figures 3H
and 3I).
As increased FGF activity has been associated with increased
lung epithelial lumen size (Tang et al., 2011), the above results
raised the possibility that the increase in FGF activity could
contribute to the branching defects observed in the Etv mutant
lung. To address this possibility, we reduced FGF signaling in
themutant lungby inactivatingonecopyofFgf10 in theEtvmutant
background, generating Shhcre/+;Etv4/;Etv5fl/fl;Fgf10+/ (here-
after Etv;Fgf10) mutants (Sekine et al., 1999). Compared to Etv
mutants, the Etv;Fgf10 mutants exhibited a mild but consistent
attenuation of the distal dilation defect starting at E11.5 (Fig-
ure S4). By E13.5, the epithelial tips of Etv;Fgf10 mutants were
roughly 50% smaller than those of Etv mutants and were not
significantly different from Etv controls (tip area normalized to
controls: 1.22 for Etv;Fgf10 mutants and 2.50 for Etv mutants,
p = 0.009 between Etv;Fgf10 and Etvmutants, p = 0.075 between
Etv;Fgf10 mutants and controls, and n = 3 each genotype) (Fig-
ures 4A–4D). While there was a slight attenuation of the reduced
branch number phenotype, the difference between Etv;Fgf10
mutant and Etv mutant lungs was not significant (tip number
normalized to controls: 0.64 for Etv;Fgf10 mutants and 0.56 for
Etvmutants, respectively,p=0.32, andn=3eachgenotype), sug-
gesting that in the Etvmutant background, the tip dilation pheno-
type responds more sensitively to Fgf10 dosage than the branch
number phenotype (Figures 4D and 4E).ier Inc.
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Figure 2. Cell Differentiation Is Largely Normal in Etv Mutant Lungs
(A–H) Immunofluorescent labeling of airway cell types using indicated markers for club cells (A and B), pulmonary neuroendocrine cells (C and D), ciliated cells
(E and F), and basal cells at E18.5 (A–F) or adult (G and H).
(I and J) Whole-mount RNA in situ hybridization of Scgb1a1 to outline the airway of E18.5 left lobe.
(K) Quantification of E18.5 airway phenotype. The terminal bronchiole size was calculated by measuring the tips of Scgb1a1-outlined bronchiole alveolar junction
(for ratio: 1.0 for controls and 1.35 for Etv mutants, p = 0.011, and n = 3). The secondary bronchi number was calculated by counting all branches off the main left
lung bronchus (for ratio: 1.0 for controls and 0.67 for mutants, p = 0,016, and n = 3; actual average tip number 6 ± 0 for controls and 4 ± 0.8 for mutants). The
terminal bronchiole number was calculated by counting the tips of Scgb1a1-outlined bronchiole alveolar junction (for ratio: 1.0 for controls and 0.47 for mutants,
p = 2.8 3 106, actual tip number 29 ± 0.6 for controls and 14 ± 0.5 for mutants).
See also Figure S2.EtvMutant Lungs Exhibited a Decrease in SHHSignaling
The above data suggest that Etv and FGF engage in an inhibitory
feedback loop, where FGF promotes the expression of Etv in the
distal epithelium, and ETV inhibits the expression of Fgf10 in the
distal mesenchyme. As Etv genes encode transcription factors
that act cell autonomously, their inhibition of Fgf10 expression
in the mesenchyme is likely through ETV regulation of an inter-
mediate cell surface/secreted factor that is expressed in the
epithelium, which in turn affects Fgf10 expression in the mesen-
chyme. One of the candidate mediators is FGF9, which is previ-
ously shown to promote Fgf10 expression in the mesenchyme
(Colvin et al., 2001; del Moral et al., 2006). However, we found
that Fgf9 expression was not altered in the Etv mutant lung
(normalized to control at 1.0: Etv mutant 0.79, p = 0.33, and
n = 3 for each). A second candidate mediator is Shh. Like Etv,
Shh is expressed in the epithelium (Bellusci et al., 1997a).
Furthermore, the distal epithelial expression of Shh is positively
regulated by FGF10 (Abler et al., 2009), and SHH in turn inhibits
Fgf10 expression in the mesenchyme (Pepicelli et al., 1998).DevelopmThese data led to the hypothesis that ETV may mediate the
FGF-SHH feedback loop by promoting Shh expression in the
distal epithelium.
To test this hypothesis, we examined whether SHH signaling is
altered in the Etv mutant lung. By in situ hybridization, we found
that the staining intensity of Shh, as well as SHH pathway read-
outs, Gli1 and Ptch1, was decreased in Etv mutant lungs
(Shhcre/+;Etv4/;Etv5fl/fl) compared to controls (Shhcre/+;Etv4+/;
Etv5fl/+) (Figures 5A–5F). This decrease was confirmed by qRT-
PCR results (Figure 5G), suggesting that Etv genes are required
to promote Shh expression in the distal epithelial tips.
Restoring SHH Signaling Activity Attenuated the Lumen
Size Phenotype in Etv Mutant Lungs
To determine if the decrease in SHH signaling in the Etv mutant
contributes to the branching phenotypes, we enhanced SHH ac-
tivity in the Etv mutant lung and assessed the epithelial branch
structure. This enhancement was achieved by using a potent
pharmacological activator of the SHH co-receptor Smoothenedental Cell 35, 322–332, November 9, 2015 ª2015 Elsevier Inc. 325
Figure 3. Etv Mutant Lungs Exhibited an
Increase in FGF Signaling Activity
(A–F) Representative E11.5 whole lung immuno-
fluorescently stained for E-cadherin (red; A and D)
and pERK (green; B and E), and the two-color
merge (C and F). pERK staining in the mutant lung
was increased in level and expanded in domain
compared to control.
(G–I) Fgf10 expression was increased as shown by
qRT-PCR at stages indicated (E11.5: 1.0 for con-
trols, 2.72 for Etv mutants, p = 0.03; E12.5: 1.0 for
controls, 2.29 for Etv mutants, p = 0.01, and n = 3
each group) (G) and RNA in situ hybridization at
E12.5 (H and I).
See also Figure S3.(Smoothened agonist, hereafter SAG) in an in vitro lung culture
system (Chen et al., 2002; Liu et al., 2003; Warburton et al.,
2010). Treatment of control lungs with SAG in culture was effec-
tive to induce the expression of the SHH pathway readout Ptch1
(Figure S5). Furthermore, Etv mutant lungs cultured in control
media without SAG retained their dilated epithelial tip (tip area
normalized to control genotype treated with DMSO: 2.10 for
Etvmutants treated with DMSO, p = 0.015, n = 3 for each geno-
type), recapitulating the in vivo phenotype (Figures 6A, 6B, 6E,
6F, and 6I). Together these data demonstrate that this in vitro
lung culture system would allow us to examine how SHH
signaling is contributing to the epithelial phenotypes in the
mutant lung.
To test whether restoring SHH activity would attenuate Etv
mutant epithelial phenotypes, we first did a SAG titration exper-
iment and selected a concentration (7.263 106 ug/ul) that does
not affect epithelial tip size (Figures 6A–6D). In contrast, treat-
ment of Etv mutant lungs with SAG at this concentration led to
a significant decrease in the epithelial tip size compared to Etv
mutant lungs treated with DMSO (tip size normalized to control
genotype treated with DMSO: 1.22 for Etv mutants treated with
SAG, and 2.10 for Etvmutants treated with DMSO, p = 0.015 be-
tween mutants treated with SAG versus DMSO, and n = 3 each
group) (Figures 6E–6I). Furthermore, in SAG-treated Etv mutant
lungs, the size of the epithelial tip was not different from either
DMSO- or SAG-treated control lungs (tip size normalized to con-326 Developmental Cell 35, 322–332, November 9, 2015 ª2015 Elsevier Inc.trol genotype treated with DMSO: 1.01 for
control genotype treated with SAG, 1.22
for SAG Etv mutants treated with SAG,
p = 0.16 between the SAG-treated con-
trols versus mutants, n = 3 each group)
(Figure 6I). These results suggested that
the decrease in SHH signaling in the Etv
mutant contributes to its phenotype and
that ETV restricts tip size partly through
promoting Shh expression.
ETV Factors Regulate Shh
Expression through a Long-Range
Shh Enhancer
A previous study characterized a cluster
of highly conserved long-range Shh en-
hancers that reside approximately 600to 900 kb upstream of the gene (Sagai et al., 2009). One of the
enhancers, termed MACS1, was shown to drive expression ac-
tivity in the lung epithelium in transient transgenic experiments.
Using an established ETV DNA binding matrix (Wei et al.,
2010), we identified three highly conserved ETV DNA binding
sites in this Shh enhancer (Figures 7A and 7B). These binding
sites are conserved across mammalian phyla, raising the possi-
bility that they are functionally relevant for the activity of the Shh
enhancer.
To assess whether ETV factors regulate Shh expression via
these predicted sites in the long-range enhancer, we first per-
formed luciferase reporter assays in cultured MLE12 cells. In
these cells, overexpression of Etv5 promoted the activity of the
Shh enhancer (Figure 7C). This promotion is dependent on intact
ETV5 DNA binding domain, as deletion of the N-terminal portion
of this domain abolished the increase in enhancer activity (Fig-
ure 7C). To determine whether the three conserved ETV binding
sites are required for the enhancer response to ETV5, we
mutated the core ETV binding sequence from 50-GGAA/T-30
(50-CCTT/A-30) to 50-CCAA/T-30 (50-GGTT/A-30) (Figure 7B). A
previous study showed that similar mutations in other conserved
ETV sites abolished the ability of ETV5 to activate transcription
via these sites (de Launoit et al., 1998). We found that the
mutated Shh enhancer no longer responded to full-length
ETV5 (Figure 7C). Furthermore, we mutated each of the putative
ETV binding sites individually and found that mutating sites 2 and
Figure 4. Reducing Fgf10 Gene Dosage in the Etv Mutant Background Led to Attenuation of the Tip Dilation Phenotype
(A–C) Representative E13.5 lung of indicated genotype with the epithelium outlined by anti-E-cadherin immunohistochemical staining. (A) Control,
(B) Etv;Fgf10+/+, and (C) Etv;Fgf10+/.
(D) Introducing the Fgf10mutant allele attenuated the branch tip area phenotype (area: 1.0 for controls, 2.5 for Etvmutants, 1.22 for Etv;Fgf10mutants; p = 0.009
for Etv mutants versus Etv;Fgf10 mutants, and p = 0.075 for controls versus Etv;Fgf10 mutants).
(E) Branch tip number was not attenuated by introducing the Fgf10mutant allele (tip number: 1.0 for controls, 0.562 for Etvmutants, 0.654 for Etv;Fgf10mutants,
p = 0.32). Quantification was carried out in n = 3 samples for each genotype.
See also Figure S4.3, but not site 1, affected responsiveness to ETV (Figure S6A).
Together, these data suggest that ETV5 is able to promote the
activity of the Shh enhancer, and both an intact DNA binding
domain on the protein and the highly conserved ETV DNA bind-
ing sites on the enhancer are required for this interaction.
A previous study showed that ETV5 can interact with NKX2-1
at the protein level to promote the expression of Sftpc in a lung
epithelial cell line (Lin et al., 2006). Within the Shh enhancer,
we identified a highly conserved NKX2-1 binding site near one
of the ETV sites (Figure 7A). In the MLE12 cell luciferase assay,
we found that ETV5 can act synergistically with NKX2-1 to
induce the activity of the Shh lung enhancer (Figure S6A).
To assess the role of the ETV binding sites for Shh enhancer
activity in an in vivo context, we generated transgenic embryos
that carry lacZ transgenes expressed under the control of
either the wild-type or mutant Shh lung enhancer. We analyzed
enhancer activity by staining for b-galactosidase (hereafter
b-gal) enzyme activity in the lungs dissected from these
embryos.
By genotyping, the injection yielded 20 embryos carrying the
wild-type Shh enhancer transgene and 23 embryos carrying
themutantShh enhancer transgene. As expected, in transgenics
carrying either construct, b-gal activity ranged from no expres-
sion to specific expression in lung epithelium, presumably due
to variations in insertion sites and transgene copy number.DevelopmNearly 50% (9/20) of the wild-type enhancer transgenic embryos
displayed only epithelium-specific expression, in agreement
with a previous study (Sagai et al., 2009), whereas such expres-
sion was observed in only 26% (6/23) of mutant Shh enhancer
transgenics (Figures 7D, 7E, and S6B). Moreover, b-gal activity
was strong in 4 of these 9 control enhancer transgenics, whereas
such strong activity was not observed in any of the mutant
enhancer transgenics (Figure S6B). Together these data suggest
that the conserved ETV binding sites are necessary for normal
and robust activity of the Shh enhancer in an in vivo context.
We then addressed whether ETV may promote Shh expres-
sion via direct binding to its enhancer. Chromatin immunoprecip-
itation experiments performed in MLE-12 cells show that immu-
noprecipitation of ETV5 led to increased pull-down of the Shh
MACS1 enhancer compared to control DNA fragment 1 kb
away from the enhancer (Figure 7F). This preferential pull-down
of the enhancer suggests that ETV5 promotes Shh expression
by directly binding to the MACS1 enhancer.
DISCUSSION
Although it is well established that multiple signals essential for
normal lung branching regulate each other’s expression on the
transcript level, relatively little is known about which transcription
factors mediate these interactions and their role in the branchingental Cell 35, 322–332, November 9, 2015 ª2015 Elsevier Inc. 327
Figure 5. SHH Signaling Was Decreased in the Etv Mutant Lung
(A–F) Representative whole-mount RNA in situ hybridization of left lobes of
E12.0–E12.5 lungs for Shh (A and B), Gli1 (C and D), and Ptch1 (E and F) with
each set of Shhcre heterozygous control and mutant as littermates.
(G) Quantification of expression by qRT-PCR (Shh: 1.0 for controls, 0.56 for Etv
mutants, p = 0.027; Gli1: 1.0 for controls, 0.77 for EtvMutants, p = 0.013; and
Ptch1: 1.0 for controls, 0.61 for Etv mutants, p = 0.022). Quantification was
carried out in nR 3 samples for each.
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genes may serve as a mediator of FGF10 function in promoting
branch growth. Instead, we found that the Etvmutant phenotype
is distinct from that of Fgf loss-of-function mutants. Our evi-
dence supports that Etv genes feed back to inhibit Fgf10 expres-
sion. And they do so via regulating the expression of Shh,
thereby acting as a key component of the FGF-SHH signaling
loop during lung branching.
It has been shown that lung branching morphogenesis follows
a largely stereotypical spatial and temporal program (Metzger
et al., 2008; Short et al., 2013). Three subroutines, planar bifurca-
tion, orthogonal bifurcation, and domain branching have been
identified to function as building blocks of the branching
sequence (Metzger et al., 2008; Short et al., 2013). Execution
of the subroutines relies on a balanced choice between branch
growth and new branch formation. For example, for planar bifur-
cation, each tip grows along one direction for a measurable
extent before splitting to follow two new directions, and the cycle
repeats. It has been postulated that the decision between growth
and bifurcation is driven by an FGF-SHH feedback loop, where
FGF stimulates growth, and SHH locally inhibits FGF, leading
to bifurcation (Hirashima et al., 2009; Menshykau et al., 2012;
Iber and Menshykau, 2013). Our data indicate that Etv serves
as a unique node of the feedback loop by controlling the balance
of these signals (Figure 7G). In the absence of Etv function, Shh
expression is reduced, while Fgf10 expression is increased.
Thereby, the Etv mutant epithelium shows prolonged growth
and delayed branch formation, resulting in fewer and larger
branch tips.
In the kidney, Etv genes have also been shown to play a role in
branching (Kuure et al., 2010). Instead of Fgf10, Etv genes are
regulated by glial cell line-derived neurotrophic factor (GDNF)
signaling via RET, also a tyrosine kinase receptor, similar to
FGF receptors. Compound Etvmutants exhibit lack of or greatly
reduce ureteric bud branching, mimicking the Gdnf/Ret mutant
phenotypes. Furthermore, in a chimeric kidney, defective
behavior of the Etv mutant cells mimics that of Ret mutant cells
(Kuure et al., 2010). Thus, in the kidney, Etv genes appear to
be a more mainstream mediator of receptor tyrosine kinase
signaling, distinct from our findings here in the lung.
Our data indicate that in the lung epithelium, Etv genes pro-
mote Shh expression. This is interesting as ETV factors have
been previously shown to inhibit Shh expression in the limb
bud, opposite to its role in the lung (Mao et al., 2009; Zhang
et al., 2009). We speculate that this difference may be due to dif-
ferences in binding partners. In the limb bud, evidence suggests
that ETV inhibits Shh expression indirectly through regulating the
homo- or heterodimerization of two E-box transcription factors,
TWIST1 and HAND2, which in turn control Shh expression (Firulli
et al., 2007; Zhang et al., 2010). In the lung, our data suggest thatier Inc.
Figure 6. SAG Treatment of EtvMutant Lungs Led to Attenuation of
Tip Dilation Phenotype
(A–H) Representative images of E11.5 lungs cultured for 24 hr in either DMSO
(A, B, E, and F) or SAG (C, D, G, and H). In the control lungs, SAG treatment did
not affect tip size (areas outlined by dashes; 1.0 DMSO versus 1.01 SAG, p =
0.89) (B and D). In the Etvmutant lungs, SAG treatment led to a reduction of tip
size toward the size of the control (2.10 DMSO versus 1.22 SAG, p = 0.015)
(F and H).
(I) Quantification of the right lung epithelial tip size (n = 3 for each).
See also Figure S5.
DevelopmETV may directly promote Shh expression through highly
conserved ETV binding sites in the MACS1 Shh lung enhancer.
MACS1 may not be the only enhancer through which ETV regu-
lates Shh expression. A recent paper reported the identification
of an additional Shh enhancer, SLGE, that displays activity in the
lung epithelium (Tsukiji et al., 2014). SLGE also contains a puta-
tive ETV binding site. Although this enhancer, different from
MACS1, is not conserved, it is possible that ETV may regulate
Shh expression through SLGE in addition to MACS1 in mice.
In addition to Etv, several other genes, Sproutys, Dusp6, and
Sef, are also commonly used as FGF signaling readouts,
because their expression is positively regulated by FGF activity
(Tsang and Dawid, 2004). Both Sproutys and Dusp6 are known
to act in the cytoplasm as direct negative regulators of the FGF
pathway. Among the FGF readouts, Etv are the only genes that
encode transcription factors. Thus we had speculated that the
phenotype of Etv mutant lungs would mimic that of loss-of-
FGF-function mutants. Instead, like Sproutys and Dusp6, Etv
genes function in lung as inhibitors of FGF activity. However, un-
like Sproutys and Dusp6, Etv genes act indirectly through regu-
lating Shh. It is intriguing that there are multiple inhibitors of
FGF activity built in downstream of the ligands and receptors,
suggesting that keeping FGF activity in check is of cardinal
importance to tissue development.
Inhibitory feedback mechanisms are often revealed as drivers
for reiterative biological processes. For example, in somite for-
mation, the transcription factors Hairy/HES-based inhibitory
feedback loop couples with signals such as Notch and FGF to
drive the segmentation of the presomitic mesoderm into a
sequence of organized blocks (Aulehla and Pourquie´, 2008). In
circadian rhythm generation, transcription factors Clock and
BMAL1 are at the core of a complex feedback machinery that re-
peats the daily cycles of sleep, metabolism, and other circadian
physiological functions (Takahashi et al., 2008). Our data pre-
sented here support the conclusion that Etv genes serve as a
critical component of an inhibitory feedback loop that controls
the periodicity of the reiterative lung branching process.
EXPERIMENTAL PROCEDURES
Mice
Mice were housed and all experimental procedures were performed in a labo-
ratory animal facility at the University of Wisconsin that is accredited by the
American Association for Accreditation of Laboratory Animal Care. This study
was approved by the University of Wisconsin Animal Care and Use Committee
and conformed to the Guide for the Care and Use of Laboratory Animals. The
embryos used in these experiments were harvested from time-mated females,
with noon the day when the vaginal plug was observed counted as E0.5. The
mutant alleles used in this study have been described previously: Etv5fl (Zhang
et al., 2009), Etv4 (Laing et al., 2000), Fgf10 (Sekine et al., 1999), and Shhcre
(Harfe et al., 2004). Shhcre/+;Etv4+/;Etv5fl/+ littermate embryos were used as
controls unless otherwise indicated.
Antibody Staining
Antibody staining was performed following a previously published protocol.
The primary antibodies used were rabbit anti-E-cadherin (Cell Signaling;
1:200 dilution), rat anti-E-cadherin (DECMA Sigma; 1:100 dilution), and rabbit
anti-phosphorylated-Erk (Cell Signaling; 1:200 dilution). The secondary
antibodies used were Cy3-conjugated goat anti-mouse, fluorescein isothiocy-
anate (FITC)-conjugated goat anti-rabbit, horseradish peroxidase (HRP)-con-
jugated goat anti-rabbit, and biotin-conjugated goat anti-rabbit (Jackson
ImmunoResearch; 1:200 dilution). The tertiary antibody used to detectental Cell 35, 322–332, November 9, 2015 ª2015 Elsevier Inc. 329
Figure 7. ETV Controls Shh Expression through Putative Binding Sites in a Long-Range Enhancer
(A) TheMACS1 lung epithelium enhancer lies approximately 800 kb upstream of the Shh transcriptional start site and contains three highly conserved ETV binding
sites (red) and one highly conserved NKX2-1 binding site (blue).
(B) The three ETV binding sites were each mutated to nucleotides previously shown to abolish binding (de Launoit et al., 1998).
(C) Relative luciferase activity from MLE12 cells transfected with either wild-type (wt) or mutant (mut) MACS1 enhancer; together with either Etv5 empty vector,
wild-type (wt) Etv5 vector, or mutant (mut) Etv5with disrupted DNA binding domain vector (1.0 for WT MACS1+no Etv5, 2.14 for WT MACS1+wt Etv5, 1.06 for wt
MACS1+mut Etv5, 0.88 for mut MACS1+no Etv5, and 1.19 mut MACS1+wt Etv5, n = 3 for each group).
(D and E) Representative b-gal staining of transgenic lungs carrying lacZ reporter driven by either wt (D) or mut (E) Shh enhancer.
(F) Percent recovery compared to inputs of either MACS1, a control fragment approximately 1.2 kb upstream ofMASC1 (control region 1), or a control fragment
approximately 800 kb downstream of MACS1 near the Shh gene (control region 2), by anti-Flag antibody against ETV5-Flag or no antibody control. The extract
was prepared from lung epithelial MLE12 cells with overexpression of Etv5-Flag and Nkx2-1 plasmids.
(G) A model of Etv regulation of lung epithelial branching. The outside circle represents the growth and bifurcation that constitute each reiterated cycle of
branching. In the Etv mutant, decrease in Shh and increase in Fgf10 lead to prolonged growth and delayed branching.
See also Figure S6.pERK in whole-mount lungs was FITC-conjugated Streptavidin (Jackson
ImmunoResearch, 1:200 dilution).
RNA In Situ Hybridization
RNA in situ hybridization was performed following a previously published pro-
tocol (Herriges et al., 2012).
Quantitative Analysis of Lung Phenotypes
Two methods were used for quantification of embryonic lung tip areas. First,
following whole-mount immunohistochemical anti-E-cadherin staining,
lungs were imaged under bright field on a Zeiss Axioscope Imager A2. Im-330 Developmental Cell 35, 322–332, November 9, 2015 ª2015 ElsevageJ software was used to draw a free-form trace around each lung bud tip,
and area within the trace was measured. Second, following whole-mount
immunofluorescent anti-E-cadherin staining, lungs were imaged on a Zeiss
510 confocal laser scanning microscope. Z stacks of single-slice images
were used to generate whole-lobe three-dimensional surface projections
using Bitplane Imaris software. Distal tip dimensions were measured in
ImageJ, and the tip volume was calculated from the formula V = 4/3pabc,
where V is the volume of an ellipsoid, and a, b, and c are radius of the tip
in each of the three dimensions. For quantifying tip number, we manually
counted anti-E-cadherin-antibody-outlined epithelial tips at the indicated
stages.ier Inc.
qRT-PCR
Total RNA was extracted from tissue using Trizol and an RNeasy-micro
QIAGEN RNA extraction kit (Invitrogen, QIAGEN). RNA was reverse-tran-
scribed using Superscript-III first-strand synthesis system (Invitrogen).
qPCR was performed using SYBRgreen (Applied Biosystems) and in an
ABI PRISM 7000 sequence detection system. The primer pairs used are
listed in Supplemental Experimental Procedures. Three biological replicates
and two technical replicates were performed for all qPCR. Expression values
were normalized using b-actin, and results were compared using the Stu-
dent’s t test.
Luciferase Reporter Assay
To generate the wild-type enhancer luciferase reporter, the mouse MACS1
Shh enhancer was amplified using primers found in Supplemental Experi-
mental Procedures and was cloned into the Pgl3 vector (Promega). To
generate the mutated enhancer luciferase reporter, the 50-GGAA/T-30 core
binding sequence was mutated to 50-CCAA/T-30 using the primers found in
Supplemental Experimental Procedures. The constructs containing the wild-
type Etv5 open reading frame and a truncated Etv5 open reading frame
were previously described (Zhang et al., 2009).
MLE-12 cells were transfected with either of the reporter constructs (200 ng)
and either an empty vector, wild-type Etv5 construct or DNA-binding-domain-
truncated mutant Etv5 construct (600 ng) using lipofectamine 2000
(Invitrogen). A Renilla luciferase plasmid was used as a transfection control.
Luciferase activity was analyzed using the Dual-Luciferase reporter system
(Promega). Three biological replicates and two technical replicates were per-
formed, and results were compared using the Student’s t test.
In Vitro Lung Culture
Lungs from control and Etv mutant embryos were harvested at E11.5. Lungs
were placed on a Nucleopore Trak-Etch membrane (Whatman; 8 um) and
cultured at the air/liquid interface with DMEM-F12 and 10% fetal bovine serum
(FBS). To activate SHH signaling, SAG was added at a final concentration of
7.26 3 106 ug/ul. DMSO was used as a diluent control. Lungs were cultured
at 37C in 5% CO2 for 24 hr before harvest and analysis.
ChIP
MLE-12 cells were transfected with 33 FLAG-tagged full-length mouse Etv5
cDNA. Approximately 1 3 107 cells per sample were cross-linked with 1%
formaldehyde for 20min at 37C. The sampleswere sonicatedwith the Covaris
E210 sonicator to obtain chromatin fragment lengths of 200–1,500 bp. Frag-
mented chromatin was incubated overnight at 4C with anti-FLAG antibody
conjugated to magnetic beads (Sigma, Slbl1128v). Immunoprecipitates were
washed sequentially with low-salt, high-salt, and LiCl wash buffers. The pro-
tein and DNA complex was eluted, and the DNA was purified by phenol/chlo-
roform extraction and ethanol precipitation. The DNAwas used as template for
qPCR.
Transgenic
The transgenic construct was produced by PCR amplification of the MACS1
enhancer and cloning it into the Hsp68-LacZ vector (Addgene). The primers
used to clone and amplify up the MACS1 enhancer can be found in Supple-
mental Experimental Procedures. Production of transgenic mice was per-
formed as previously reported (Anderson et al., 2013).
b-gal Staining
Lungs from control and mutant Shh transgenic lungs were harvested at E11.5.
Lungs were fixed in 4% paraformaldehyde (PFA) at 4C for 10 min and put
through a standard b-gal staining protocol. All lungs were exposed to the
b-gal stain for 2 hr. After 2 hr, the lungs were removed from the stain, put in
a 4% PFA postfix, and imaged.
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